Any time
Open links in new tab
- FezolinetantA new medication may bring relief to women struggling with the exasperating hot flashes of menopause. In May 2023, the FDA approved fezolinetant (Veozah). It's the first drug specifically designed to reduce the frequency and severity of flushing and sweating spells that occur as a woman's estrogen levels fall.Phone: (877) 649-9457Email: hhp_info@health.harvard.eduwww.health.harvard.edu/womens-health/fda-approves-first-drug-designed-to-tre…
- People also ask
FDA Approves Novel Drug to Treat Moderate to Severe Hot …
Hot flashes treatment: FDA approves new drug for night sweats
Elinzanetant: Experimental pill cut hot flashes and improved sleep …
A new drug shows promise for hot flashes due to menopause
New help for hot flashes - Harvard Health
Nov 1, 2023 · Learn about fezolinetant (Veozah), the first nonhormonal medication approved by the FDA for menopausal hot flashes and night sweats. This article also reviews other nonhormonal options and explains the causes …
FDA Approves New Drug to Treat Hot Flashes - The New York Times
FDA greenlights a new type of drug for menopausal hot flashes
Menopause drug Veozah approved by FDA to treat hot …
May 13, 2023 · The Food and Drug Administration has approved Veozah (fezolinetant), a drug to treat symptoms of menopause. The drug, produced by Tokyo-headquartered Astellas Pharma, was found to...
What to Know About the New Treatment for Hot Flashes
May 12, 2023 · The Food and Drug Administration approved a new nonhormonal oral drug Friday, under the brand name Veozah, designed to treat menopausal hot flashes. The drug provides women with a “safe and ...
Related searches for New Medication for Hot Flashes